Table 2.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
Parameter | HR | 95%CI | P | HR | 95%CI | P |
Gender | 1.300 | 0.863–1.958 | 0.210 | |||
(Female vs. Male) | ||||||
Age | 1.258 | 0.849–1.863 | 0.252 | |||
(<50 vs. ≥50) | ||||||
Lauren’s classification | 1.195 | 0.812–1.759 | 0.365 | |||
(Intestinal vs. Diffuse) | ||||||
Clinical stage | 4.381 | 2.712–7.075 | <0.001 | 3.989 | 1.454–10.943 | 0.007 |
(I-II vs. III-IV) | ||||||
Tumor depth | 2.288 | 1.526–3.431 | <0.001 | 1.762 | 1.134–2.737 | 0.012 |
(T1-T2 vs. T3-T4) | ||||||
Lymph node metastasis | 3.752 | 2.385–5.902 | <0.001 | 0.836 | 0.313–2.234 | 0.721 |
(N0-N1 vs. N2-N3) | ||||||
Distant metastasis | 19.116 | 8.961–40.779 | <0.001 | 8.700 | 3.938–19.223 | <0.001 |
(M0 vs. M1) | ||||||
SNHG7 expression | 2.806 | 1.871–4.207 | <0.001 | 1.652 | 1.045–2.612 | 0.032 |
(Low vs. High) |
HR, hazard ratio; 95% CI, 95% confidence interval;